New investigation reveals that patients who eat successful consequence to nutrient cues suffer much weight connected GLP-1 therapy, pointing to outer eating behaviour arsenic a powerful predictor of curen success.
Study: Association betwixt eating behaviour patterns and nan therapeutic efficacy of GLP-1 receptor agonists successful individuals pinch type 2 diabetes: a multicenter prospective observational study. Image credit: Ekaterina Markelova/Shutterstock.com
A caller study published successful Frontiers successful Clinical Diabetes and Healthcare reports that changes successful outer eating behaviour whitethorn power nan glucose-lowering and assemblage weight guidance efficacy of glucagon-like peptide-1 receptor agonists successful type 2 diabetic patients.
Background
In nan existent study, researchers aimed to understand nan narration betwixt eating behaviors and nan therapeutic efficacy of GLP-1RAs successful patients pinch type 2 diabetes.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are wide utilized medications for type 2 glucosuria and obesity. These medications person shown precocious effectiveness successful reducing humor glucose levels and triggering clinically meaningful weight loss.
Despite well-established therapeutic efficacy, nan glucose- and assemblage weight-lowering effects of GLP-1RAs grounds important interindividual variability. Emerging grounds suggests that individuals' eating behaviors whitethorn power their consequence to GLP-1RA therapy.
Eating behaviour is importantly associated pinch managing type 2 glucosuria and obesity. Various psychosocial, behavioral, and biology factors are imaginable determinants of eating behavior. Certain eating behaviors, including outer eating, affectional eating, and restrained eating, person been linked to overeating and weight gain.
External eating behaviour refers to nutrient intake triggered by outer stimuli, specified arsenic nan show aliases smell of food. In contrast, affectional eating behaviour is defined arsenic nutrient intake triggered by antagonistic emotions, specified arsenic worry and depression. These 2 eating behaviors are associated pinch excessive intake of high-calorie foods and weight gain.
On nan different hand, restrained eating behaviour is defined arsenic nan conscious regularisation of nutrient intake to power assemblage weight. Restrained eating is often linked to amended weight control, but erstwhile done successful excess aliases poorly managed, it tin trigger overeating. In this study, restrained eating showed nary important relationship to semipermanent outcomes.
Study design
The study included a full of 92 diabetic patients who were receiving GLP-1RA therapy from 4 institutions successful Japan.
The participants were assessed for changes successful objective parameters, including fasting humor glucose and glycated hemoglobin, assemblage weight, assemblage fat percentage, and eating behaviors complete 12 months. Specifically, nan assessments were conducted astatine baseline (initiation of GLP-1RA therapy) and astatine 3 months and 12 months post-therapy initiation.
Key findings
The proceedings showed that nan 12-month GLP-1RA therapy importantly improved glycated hemoglobin (a measurement of glycemic control), assemblage weight, and assemblage fat percent successful diabetic patients. At nan aforesaid time, skeletal musculus wide was preserved contempt weight loss. The therapy besides led to important reductions successful liver enzymes and full cholesterol, pinch HDL cholesterin expanding and triglycerides showing a non-significant improving trend, alternatively than uniformly improving nan full lipid profile.
The study of dietary intake revealed important reductions successful full calorie and macronutrient intake pursuing GLP-1RA therapy. External eating behaviour scores persistently improved astatine 3- and 12-months post-treatment.
Emotional eating behaviour showed a important first simplification astatine period 3, which returned to nan baseline shape by 12 months. In contrast, restrained eating behaviour showed a transient summation astatine period 3, which returned to nan baseline shape by 12 months.
Among nan 3 eating behaviors analyzed, a higher baseline outer eating behaviour people was associated pinch greater assemblage weight simplification astatine period 12, and a inclination towards improved glycemic outcomes.
Notably, location was immoderate variability betwixt different GLP-1RAs: dulaglutide, oral semaglutide, and injectable semaglutide each importantly reduced some HbA1c and assemblage weight, while liraglutide improved HbA1c but did not lead to important weight reduction, apt owed to nan smaller number of participants receiving this drug.
Study significance
The study findings show that GLP-1RAs tin importantly amended glycemic power and trim assemblage weight and assemblage fat percent successful diabetic patients aft 12 months of curen successful existent objective settings. Besides metabolic improvements, GLP-1RA therapy tin substantially trim outer eating behavior, which is simply a cardinal psychological facet linked to overeating and obesity.
The relation betwixt outer eating behaviour and objective outcomes observed successful nan study suggests that outer eating behaviour scores whitethorn service arsenic a useful behavioral predictor of GLP-1RA therapeutic efficacy and thief guideline personalized therapeutic strategies successful objective practice. The observed simplification successful outer eating behaviour scores suggests that GLP-1RAs whitethorn thief suppress overeating triggered by outer stimuli, specified arsenic nan appearance, aroma, aliases nutrient availability.
Existing grounds demonstrates hyperactivation of reward-related encephalon regions successful obese individuals successful consequence to ocular nutrient stimuli. GLP-1RAs person been recovered to suppress this hyperactivation, which could thief to explicate nan observed simplification successful outer eating behaviour pursuing GLP-1RA therapy. Furthermore, erstwhile studies person shown that individuals pinch precocious affectional eating behaviour grounds little suppression of neural responses to nutrient stimuli during GLP-1RA therapy, which tin perchance trim their curen responsiveness. This whitethorn thief explicate nan deficiency of relation observed betwixt affectional eating behaviour and semipermanent objective outcomes.
It is indicated that participants pinch higher baseline outer eating scores knowledgeable a importantly greater simplification successful assemblage weight but only a inclination towards improved glycemic power pursuing GLP-1RA therapy. Mechanistic grounds indicates that GLP-1RAs trim humor glucose levels by expanding insulin secretion and decreasing glucagon secretion. Since these pathways are unaffected by eating behaviors, only a inclination towards improved glycemic power has been observed among participants pinch higher baseline outer eating behavior.
Because of nan observational study design, nan study could not find nan causality of observed associations. Furthermore, nan study study did not see manner factors, psychological conditions, aliases socioeconomic position arsenic imaginable confounding factors, which whitethorn power nan findings.
The study analyzed self-reported information connected eating behaviors, which whitethorn present callback bias aliases societal desirability bias. The study organization chiefly included highly motivated individuals who were much inclined to prosecute successful manner modifications and adhere to treatment, which whitethorn restrict nan generalizability of nan findings to a wide scope of diabetic populations.
Download your PDF transcript now!
Journal reference:
- Koide Y. (2025). Association betwixt eating behaviour patterns and nan therapeutic efficacy of GLP-1 receptor agonists successful individuals pinch type 2 diabetes: a multicenter prospective observational study. Frontiers successful Clinical Diabetes and Healthcare. https://doi.org/10.3389/fcdhc.2025.1638681. https://www.frontiersin.org/journals/clinical-diabetes-and-healthcare/articles/10.3389/fcdhc.2025.1638681/full
English (US) ·
Indonesian (ID) ·